PMFA
EDIT icon

Plante Moran Financial Advisors’s Editas Medicine EDIT Stock Holding History

Plante Moran Financial Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$324 Hold
100
– – ﹤0.01% 1282
2026
Q1 		$247 Hold
100
– – ﹤0.01% 697
2025
Q4 		$205 Hold
100
– – ﹤0.01% 785
2025
Q3 		$347 Hold
100
– – ﹤0.01% 748
2025
Q2 		$220 Hold
100
– – ﹤0.01% 750
2025
Q1 		$116 Hold
100
– – ﹤0.01% 776
2024
Q4 		$127 Hold
100
– – ﹤0.01% 888
2024
Q3 		$341 Hold
100
– – ﹤0.01% 843
2024
Q2 		$467 Hold
100
– – ﹤0.01% 745
2024
Q1 		$742 Buy
+100
New +$831 ﹤0.01% 795

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Plante Moran Financial Advisors's EDIT Position: Q2 2026 in Review

Plante Moran Financial Advisors held its Editas Medicine (EDIT) position steady in Q2 2026 at 100 shares worth $324. The position accounts for ﹤0.01% of the portfolio, ranked #1282.

Plante Moran Financial Advisors first reported a position in EDIT in Q1 2024 and has held it in 10 quarters since. The position peaked at $742 in Q1 2024. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Plante Moran Financial Advisors held 100 shares of Editas Medicine worth $324 as of Q2 2026.
  • Plante Moran Financial Advisors left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #1282 holding.
  • Plante Moran Financial Advisors first reported a position in Editas Medicine in Q1 2024 and has held it in 10 quarters since.
  • Plante Moran Financial Advisors's Editas Medicine position peaked at $742 in Q1 2024.
  • 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.